1. Home
  2. Labeler Index
  3. Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
  4. 71731-4171
  5. Product Images: Eribulin Mesylate

Product Images Eribulin Mesylate

View Photos of Packaging, Labels & Appearance

Table of Contents

  1. Draft Carton Label - Draft Carton Label
  2. Draft Container Label - Draft Container Label
  3. Figure 1 - Fig 1
  4. Figure 2 - Fig 2
  5. formula structure - Figure 01 formula structure

Product Label Images

The following 5 images provide visual information about the product associated with Eribulin Mesylate NDC 71731-4171 by Chia Tai Tianqing Pharmaceutical Group Co., Ltd., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Draft Carton Label - Draft Carton Label

Draft Carton Label - Draft Carton Label

This text provides information about Eribulin Mesylate Injection, a medication indicated for intravenous use and containing a cytotoxic agent. Each single-dose vial contains 1 mg of Eribulin Mesylate in 2 mL of solution. The dosage and use instructions should be followed as per the accompanying prescribing information. The medication should be stored between 15°C to 30°C (59°F to 86°F) and should not be frozen or refrigerated. It is important to discard any unused portion of the single-dose vial.*

Draft Container Label - Draft Container Label

Draft Container Label - Draft Container Label

This text provides information on Eribulin Mesylate Injection in a 1 mg/2 mL (0.5 mg/ml) dosage for intravenous use. It emphasizes that it is a single-dose vial, and any unused portion must be discarded. The solution is sterile and should be stored between 20°C to 25°C (68°F to 77°F). It cautions against freezing or refrigerating the product due to its cytotoxic nature. The manufacturer is The WhiteOak Group, LLC, based in Washington DC, with the product being made in China. It also mentions that the dosage and usage instructions are available in the accompanying prescribing information.*

Figure 1 - Fig 1

Figure 1 - Fig 1

Figure 2 - Fig 2

Figure 2 - Fig 2

formula structure - Figure 01 formula structure

formula structure - Figure 01 formula structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.